Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J F Buchanan

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Biochemical and Biophysical Research Communications|December 29, 1978
Formation of 9,10-epoxypalmitate and 9,10-dihydroxypalmitate from palmitoleic acid by a soluble system from Bacillus megateriumJ F Buchanan, A J Fulco
Medical Toxicology and Adverse Drug Experience|January 1, 1988
'Designer drugs'. A problem in clinical toxicologyJ F Buchanan, C R Brown
Drug Intelligence & Clinical Pharmacy|February 1, 1984
Drug-induced infertilityJ F Buchanan, L J Davis
Journal of Chromatography|November 9, 1984
High-performance liquid chromatographic procedure for the determination of di-(2-ethylhexyl)phthalate in human blood specimens. Problems of variable-extraction yield and the use of standard addition for calibrationG M Pollack, R L Slaughter, J F Buchanan, et al.
Parasitology|March 15, 2003
Fasciola hepatica: surface and internal tegumental changes induced by treatment in vitro with the sulphoxide metabolite of albendazole ('Valbazen')J F Buchanan, I Fairweather, G P Brenna, et al.
Toxicology and Applied Pharmacology|June 30, 1985
Circulating concentrations of di(2-ethylhexyl) phthalate and its de-esterified phthalic acid products following plasticizer exposure in patients receiving hemodialysisG M Pollack, J F Buchanan, R L Slaughter, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Biochemical and Biophysical Research Communications|December 29, 1978
Formation of 9,10-epoxypalmitate and 9,10-dihydroxypalmitate from palmitoleic acid by a soluble system from Bacillus megateriumJ F Buchanan, A J Fulco
Medical Toxicology and Adverse Drug Experience|January 1, 1988
'Designer drugs'. A problem in clinical toxicologyJ F Buchanan, C R Brown
Drug Intelligence & Clinical Pharmacy|February 1, 1984
Drug-induced infertilityJ F Buchanan, L J Davis
Journal of Chromatography|November 9, 1984
High-performance liquid chromatographic procedure for the determination of di-(2-ethylhexyl)phthalate in human blood specimens. Problems of variable-extraction yield and the use of standard addition for calibrationG M Pollack, R L Slaughter, J F Buchanan, et al.
Parasitology|March 15, 2003
Fasciola hepatica: surface and internal tegumental changes induced by treatment in vitro with the sulphoxide metabolite of albendazole ('Valbazen')J F Buchanan, I Fairweather, G P Brenna, et al.
Toxicology and Applied Pharmacology|June 30, 1985
Circulating concentrations of di(2-ethylhexyl) phthalate and its de-esterified phthalic acid products following plasticizer exposure in patients receiving hemodialysisG M Pollack, J F Buchanan, R L Slaughter, et al.
Pageof 1